Shared analyst passwords detected during FDA inspection – warning letter risk explained
During the inspection, several alarming signs indicated a potential data integrity issue:Click to read the full article.
Data Integrity Breach Case Studies
Backdated laboratory records during internal audit – warning letter risk explained
The initial signal indicating a potential breach of data integrity was an unusual discrepancy between the recorded results in laboratory notebooks and the electronic data system. These discrepancies were discovered…
Backdated laboratory records during internal audit – warning letter risk explained
During a routine internal audit, several symptoms raised red flags concerning the integrity of laboratory records. These included:Click to read the full article.
Backdated laboratory records during data review – 483 observation breakdown
When laboratory records are backdated, various signals may indicate the issue, often presenting themselves subtly initially. Observations may include:Click to read the full article.
Backdated laboratory records during data review – 483 observation breakdown
The initial detection of the issue began during a routine internal audit of the laboratory records. Observations made included:Click to read the full article.
Backdated laboratory records during data review – remediation failure analysis
During a routine bi-monthly data review, discrepancies were observed in laboratory records related to batch release testing. The quality control (QC) manager noted that some records appeared to have dates…
Shared analyst passwords detected during system validation – warning letter risk explained
In this case, the initial detection of shared analyst passwords was marked by several key symptoms:Click to read the full article.
QA oversight failure in DI during FDA inspection – warning letter risk explained
The initial triggering event in this case was an internal audit that uncovered inconsistent data entries in batch production records (BPRs). Symptoms included:Click to read the full article.
Repeat DI lapses tolerated during data review – warning letter risk explained
The detected symptoms of potential data integrity lapses manifested through anomalies observed during routine data reviews. Specific signs included:Click to read the full article.
Uncontrolled spreadsheet calculations during data review – remediation failure analysis
The initial cues indicating potential issues began with staff reports made during routine data review. Analysts noted unexplained variances in batch reports and discrepancies between spreadsheet outputs and registered data…
Audit trail deletion identified during FDA inspection – 483 observation breakdown
During routine data review prior to an FDA inspection, the Quality Assurance (QA) team detected significant discrepancies in the audit logs for a batch of sterile injectable products. Key symptoms…
Audit trail deletion identified during data review – 483 observation breakdown
The initial symptom of a data integrity breach often presents during routine data reviews. In this case, a Quality Control Analyst noticed irregularities when reconciling electronic batch records against physical…